YOSHIAKI NAGATANI

Has grant

Kobe University Hospital

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Development of novel cancer immunotherapy by controlling MDSCs

Open Date: 2018-01-01

Close Date: 2020-01-01

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Hironobu Minami

JAPAN

View details

Yoshinori Imamura

Assistant Professor

Kobe University Hospital

JAPAN

View details

Yasuyuki Saito

Associate Professor

Kobe University Graduate School of Medicine

JAPAN

View details

Takayuki Takahama

Lecturer

Kindai University Hospital

JAPAN

View details

Yohei Funakoshi

Kobe University Hospital

JAPAN

View details

Kouichi Ohe

Kyoto University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

YOSHIAKI NAGATANI

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Response to <scp>mRNA SARS‐CoV</scp>‐2 vaccination evaluated by B‐cell receptor repertoire after tixagevimab/cilgavimab administration

ASO Visual Abstract: The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases

The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases

Transition of the PD‑1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re‑challenge

Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer

Identification of Breast Cancer Stem Cells Using a Newly Developed Long-acting Fluorescence Probe, C5S-A, Targeting ALDH1A1

Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial

Serum Soluble Interleukin-2 Receptor as a Potential Biomarker for Immune-related Adverse Events

Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells

Microsatellite instability-high colorectal cancer patient-derived xenograft models for cancer immunity research

Collaborators (6)

Hironobu Minami

Yoshinori Imamura

Yasuyuki Saito

Takayuki Takahama

Yohei Funakoshi

Kouichi Ohe

Make your next move.